Anticoagulation pour l'épuration extrarénale
作者： M MONCHI , D THEBERT
DOI: 10.1016/J.REAURG.2005.09.015
关键词: Hemodialysis 、 Intensive care 、 Renal replacement therapy 、 Hemofiltration 、 Medicine 、 Gynecology
摘要: Resume L'epuration extrarenale (EER) necessite une anticoagulation afin de prevenir les risques coagulation du circuit. Les thromboses repetees circuit d'EER engendrent augmentation des couts, la charge en soins et besoins transfusionnels. L'heparine peut induire un risque hemorragique important. Ce a motive le developpement techniques alternatives telles que reduction doses d'heparine, l'association heparine–protamine, heparines bas poids moleculaire, prostacycline, l'anticoagulation regionale au citrate. Le but cet article est presenter revue differentes possibilites d'anticoagulation epuration extrarenale.
sci-hub.se 参考文章(46)
V.A. Kumar, J.Y. Yeun, T.A. Depner, B.R. Don, Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. International Journal of Artificial Organs. ,vol. 27, pp. 371- 379 ,(2004) , 10.1177/039139880402700505
Ponticelli C, Martinelli I, Moia M, Graziani G, Tenconi Pm, Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients. Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna. ,vol. 12, pp. 67- 71 ,(1997)
Anastassiades E, Flynn A, Lane Da, Curtis, Ireland H, A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin. Clinical Nephrology. ,vol. 32, pp. 290- 296 ,(1989)
Bernd Jaeger, Andreas Greinacher, Petra Eichler, Heinz-Juergen Friesen, Norbert Lubenow, Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance Blood. ,vol. 96, pp. 2373- 2378 ,(2000) , 10.1182/BLOOD.V96.7.2373
Giovanni Di Minno, Jose Martinez, Mar-Lee McKean, Jose De La Rosa, James F. Burke, Scott Murphy, Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. The American Journal of Medicine. ,vol. 79, pp. 552- 559 ,(1985) , 10.1016/0002-9343(85)90051-8
P Glaser, R Guesde, J.J Rouby, B Eurin, Haemodialysis without heparin is possible. The Lancet. ,vol. 314, pp. 579- 580 ,(1979) , 10.1016/S0140-6736(79)91631-3
Mehran Monchi, Denis Berghmans, Didier Ledoux, Jean-Luc Canivet, Bernard Dubois, Pierre Damas, Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Medicine. ,vol. 30, pp. 260- 265 ,(2004) , 10.1007/S00134-003-2047-X
Joachim Schrader, Werner Stibbe, Victor W. Armstrong, Michael Kandt, Rainer Muche, Heinz Köstering, Dietrich Seidel, Fritz Scheler, Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration Kidney International. ,vol. 33, pp. 890- 896 ,(1988) , 10.1038/KI.1988.81
YOSHIKAZU MORITA, RICHARD W. JOHNSON, RALPH E. DORN, DONALD S. HALL, Regional anticoagulation during hemodialysis using citrate. The American Journal of the Medical Sciences. ,vol. 242, pp. 32- 43 ,(1961) , 10.1097/00000441-196107000-00005
Richard D. Swartz, Friedrich K. Port, Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin Kidney International. ,vol. 16, pp. 513- 518 ,(1979) , 10.1038/KI.1979.157